Friday, May 17th, 2024
10:00 -10:15 Congress Opening
10:15 - 12:30 Plenary Session 1: Emerging trends in cancer-associated thrombosis (Part I)
Chairs: Benjamin Brenner (Israel), Paolo Simioni (Italy)
Endothelial cell dysfunction in cancer: a modulator of CAT and metastasis?
Jamie O’Sullivan (Ireland)
Artificial Intelligence in CAT
Rushad Patell (USA)
The gut microbiome in cancer and thrombosis
Christoph Reinhardt (Germany)
Stroke in patients with cancer
Deborah Siegal (Canada)
Selected Abstract
OC01_IMMUNE CHECKPOINT BLOCKADE PROMOTES THROMBOSIS VIA T-CELL AND NEUTROPHIL ACTIVATION, AND TUMOR-CELL ASSOCIATED TISSUE FACTOR (TF) IN A MURINE MODEL OF COLORECTAL CANCER
Y Shim, B Sharma, Y Hisada, N Mackman, J Palumbo, M Diaz-Montero, A Khorana, Keith McCrae (USA)
OC02_NAVIGATING THE INTERPLAY OF CANCER, HEMOSTASIS, AND THROMBOSIS: INVESTIGATING TISSUE FACTOR IN COLORECTAL CANCER (CALGB/SWOG 80405)
Sandra Algaze, Y. Yang, J. Millstein, F. Battaglin, S. Soni, P. Mittal, K. Ashouri, A. Wong, P. Jayachandran, H. Arai, J. H. Lo, W. Zhang, L. Torres-gonzalez, H. Liebman, H. J. Lenz (USA)
12:30 -13:30 Debate: Do we need more complex and specific RAMs for CAT?
Chairs: Paolo Prandoni (Italy), Mario Mandalà (Italy)
YES: Andres Munoz-Martin (Spain)
NO: Ingrid Pabinger (Austria)
13:30 – 14:30 Lunch Sessions
14:30 – 15:00 Coffee
15:00 – 17:15 Plenary Session 2: Emerging trends in cancer-associated thrombosis (Part II)
Chairs: Laurent Bertoletti (France), Francesco Dentali (Italy)
Trends and Updates on the Epidemiology of Cancer-Associated Thrombosis
Ang Li (USA)
Cancer immunotherapy in CAT
Claudine Graf (Germany)
Bleeding and thrombosis during CAR-T therapy
Elena Rossi (Italy)
Location of metastasis and complications of anticoagulant treatment
Maria Barca-Hernando (Spain)
Selected Abstracts
OC03_PREDICTION OF CLINICALLY SIGNIFICANT BLEEDING IN PATIENTS ANTICOAGULATED FOR CANCER-ASSOCIATED VENOUS THROMBOEMBOLISM: VALIDATION OF THE B-CAT SCORE IN A COHORT OF PATIENTS FROM THE TESEO STUDY
Javier López Robles, M. Sánchez Cánovas, C. Iglesias, L. Ortega Morán, L. Sánchez Togneri, J. Rubio, I. Fernández Pérez, M. García De Herreros, I. García Escobar, R. Porta, E. Brozos, M. Carmona Campos, E. Martínez De Castro, H. Olivares, T. Quintanar, S. García Adrián, M. Covela Rúa, A. Carmona Bayonas, P. Jiménez Fonseca, Aj. Muñoz Martín, On Behalf of Teseo Registry Investigators (Spain)
OC04_TISSUE FACTOR PATHWAY-RELATED BIOMARKERS IN PANCREATIC CANCER: PLASMA LEVELS OF ACTIVATED FACTOR VII-ANTITHROMBIN COMPLEX MAY PREDICT VENOUS THROMBOEMBOLISM
Elena Campello, M. Spizzo, A. Castagna, F. T. M. Bosch, F. I. Mulder, N. Van Es, S. Gavasso, P. Pattini, A. Rousseau, P. Van Dreden, S. Friso, H. R. Büller, P. Simioni, N. Martinelli (Italy, The Netherlands, France)
17:15 - 17:45 Coffee Break
17:45 – 18:45 Plenary Lecture: 8th Simon Karpatkin Memorial Lecture
The Conference Chairs
Introduction to Lecture: Alok A. Khorana (USA)
VTE treatment in patients with cancer: Reflections on an evolving landscape
Agnes Y.Y. Lee (Canada)